Protein kinase C alpha expression in normal breast, ductal carcinoma in situ and invasive ductal carcinoma

This publication has 7 references indexed in Scilit:

• A Phase II trial of aprinocarsen, an antisense oligonucleotide inhibitor of protein kinase C α, administered as a 21‐day infusion to patients with advanced ovarian carcinoma
  Cancer, 2004
• Antisense therapy directed to protein kinase C-alpha (affinitak, LY900003/ISIS 3521): Potential role in breast cancer
  Seminars in Oncology, 2003
• Sequential Activation of Protein Kinase C (PKC)-α and PKC-ε Contributes to Sustained Raf/ERK1/2 Activation in Endothelial Cells under Mechanical Strain
  Journal of Biological Chemistry, 2001
• The α Isoform of Protein Kinase C Is Involved in Signaling the Response of Desmosomes to Wounding in Cultured Epithelial Cells
  Molecular Biology of the Cell, 2000
• Elevation of protein kinase A and protein kinase C activities in malignant as compared with normal human breast tissue
  Published by Elsevier ,1996
• Tumor invasion and metastases: biochemical mechanisms
  Published by Springer Nature ,1988
• Phorbol esters inhibit the proliferation of MCF-7 cells
  Biochemical Pharmacology, 1986